Furthermore, anti-tumor defense requires recognition of tumor antigens by CTLs' TCRs and strengthening CTL/tumor cell contacts by LFA-1-ICAM-1 and/or CD103-E-cadherin interaction [35]–[39]. Here, ICAM1 is linked to neoplasm.